Status:
COMPLETED
Evaluation of the ChronoS Therapy on the Severity of Sleep Disturbances Among Patients With Mood Disorders: A Within-subjects Study
Lead Sponsor:
Centre Hospitalier St Anne
Conditions:
Insomnia Due to Mental Disorder
Eligibility:
All Genders
18-99 years
Phase:
NA
Brief Summary
A new psychotherapy has been developed within the Psychiatry, Sleep and Chronobiology Reference Center (ChronoS) since January 2022.Results have shown relevant clinical interest on insomnia symptoms, ...
Detailed Description
Insomnia affects 85% of patients with a mood disorder during depressive phases and more than 50% will suffer from insomnia symptoms after remission. The treatment of insomnia with mood disorders repre...
Eligibility Criteria
Inclusion
- Inclusion Criteria:
- Aged over 18 years old
- Diagnosed with
- A mood disorder (bipolar or unipolar) recognized in the DSM-5
- Chronic insomnia disorder recognized in the DSM-5
- Must have obtained a score ≥ 8 on the ISI scale evaluated by the clinician, that indicates at least an insomnia of mild intensity
- Exclusion Criteria :
- Patients aged under 18 years old
- Patients with psychotic disorder
- Patients who have previously undergone CBT insomnia or other targeted cognitive behavioral therapy
- Patients under guardianship, curatorship or protection of the court
Exclusion
Key Trial Info
Start Date :
April 30 2023
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
March 30 2025
Estimated Enrollment :
67 Patients enrolled
Trial Details
Trial ID
NCT07180290
Start Date
April 30 2023
End Date
March 30 2025
Last Update
September 18 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Centre CHRONOS
Paris, France